Showing results (791-800 of 812) with videos related to
Sort By:
Pageof 82
Drug Design, Development and Therapy|May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III StudyJong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.Nature|October 9, 2009
Origins and functional impact of copy number variation in the human genomeDonald F Conrad, Dalila Pinto, Richard Redon, et al.Clinical Therapeutics|September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential HypertensionHae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.Clinical Therapeutics|July 24, 2017
Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical TrialIl Suk Sohn, Chong-Jin Kim, Taehoon Ahn, et al.Korean Circulation Journal|September 29, 2017
Korean Guidelines for Diagnosis and Management of Chronic Heart FailureMin-Seok Kim, Ju-Hee Lee, Eung Ju Kim, et al.Clinical Therapeutics|August 10, 2016
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan MonotherapyKwang-Il Kim, Mi-Seung Shin, Sang-Hyun Ihm, et al.Trials|July 3, 2019
Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trialMin-Gu Kang, Kwang-Il Kim, Sang Hyun Ihm, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|August 24, 2023
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trialEun Joo Cho, Moo Hyun Kim, Young-Hak Kim, et al.Clinical Therapeutics|September 6, 2020
Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical TrialSang-Hyun Ihm, Woo-Baek Chung, Jong-Min Lee, et al.Journal of Clinical Medicine|March 6, 2021
Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort StudyIn-Jeong Cho, Jeong-Hun Shin, Mi-Hyang Jung, et al.Pageof 82